Our results indicate that diabetes increases the levels of NFκB, NLRP3 inflammasome, and IL-1β in the hippocampus, suggesting that activation of diabetes-induced NLRP3 and enhanced secretion of IL-1β contribute to the progression of diabetic encephalopathy. Here, NLRP3 is linked to diabetic encephalopathy.